Literature DB >> 26527645

AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.

Katsuhiko Hayashi1, Ryosuke Nakashima2, Keisuke Sakurai2, Kimie Kitagawa3, Seiji Yamasaki4, Kunihiko Nishino4, Akihito Yamaguchi5.   

Abstract

UNLABELLED: The AcrAB-TolC system in Escherichia coli is an intrinsic RND-type multidrug efflux transporter that functions as a tripartite complex of the inner membrane transporter AcrB, the outer membrane channel TolC, and the adaptor protein AcrA. Although the crystal structures of each component of this system have been elucidated, the crystal structure of the whole complex has not been solved. The available crystal structures have shown that AcrB and TolC function as trimers, but the number of AcrA molecules in the complex is now under debate. Disulfide chemical cross-linking experiments have indicated that the stoichiometry of AcrB-AcrA-TolC is 1:1:1; on the other hand, recent cryo-electron microscopy images of AcrAB-TolC suggested a 1:2:1 stoichiometry. In this study, we constructed 1:1-fixed AcrB-AcrA fusion proteins using various linkers. Surprisingly, all the 1:1-fixed linker proteins showed drug export activity under both acrAB-deficient conditions and acrAB acrEF double-pump-knockout conditions regardless of the lengths of the linkers. Finally, we optimized a shorter linker lacking the conformational freedom imparted by the AcrB C terminus. These results suggest that a complex with equal amounts of AcrA and AcrB is sufficient for drug export function. IMPORTANCE: The structure and stoichiometry of the RND-type multidrug exporter AcrB-AcrA-TolC complex are still under debate. Recently, electron microscopic images of the AcrB-AcrA-TolC complex have been reported, suggesting a 1:2:1 stoichiometry. However, we report here that the AcrB-AcrA 1:1 fusion protein is active for drug export under acrAB-deficient conditions and also under acrAB acrEF double-deficient conditions, which eliminate the aid of free AcrA and its close homolog AcrE, indicating that the AcrB-AcrA 1:1 stoichiometry is enough for drug export function. In addition, the AcrB-AcrA fusion protein can function without the aid of free AcrA. We believe that these results are very important for considering the structure and mechanism of AcrAB-TolC-mediated multidrug export.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26527645      PMCID: PMC4751787          DOI: 10.1128/JB.00587-15

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  61 in total

1.  AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex.

Authors:  Elena B Tikhonova; Helen I Zgurskaya
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

2.  Role of histone-like protein H-NS in multidrug resistance of Escherichia coli.

Authors:  Kunihiko Nishino; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

3.  The C-terminal domain of AcrA is essential for the assembly and function of the multidrug efflux pump AcrAB-TolC.

Authors:  Qiang Ge; Yoichi Yamada; Helen Zgurskaya
Journal:  J Bacteriol       Date:  2009-05-01       Impact factor: 3.490

4.  Tracing ancestors and relatives of Escherichia coli B, and the derivation of B strains REL606 and BL21(DE3).

Authors:  Patrick Daegelen; F William Studier; Richard E Lenski; Susan Cure; Jihyun F Kim
Journal:  J Mol Biol       Date:  2009-09-15       Impact factor: 5.469

5.  Roles of TolC-dependent multidrug transporters of Escherichia coli in resistance to beta-lactams.

Authors:  Kunihiko Nishino; Junko Yamada; Hidetada Hirakawa; Takahiro Hirata; Akihito Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

Review 6.  Pseudomonas aeruginosa - a phenomenon of bacterial resistance.

Authors:  Tanya Strateva; Daniel Yordanov
Journal:  J Med Microbiol       Date:  2009-06-15       Impact factor: 2.472

7.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640

Review 8.  Mechanism of coupling drug transport reactions located in two different membranes.

Authors:  Helen I Zgurskaya; Jon W Weeks; Abigail T Ntreh; Logan M Nickels; David Wolloscheck
Journal:  Front Microbiol       Date:  2015-02-24       Impact factor: 5.640

9.  The SWISS-MODEL Repository and associated resources.

Authors:  Florian Kiefer; Konstantin Arnold; Michael Künzli; Lorenza Bordoli; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2008-10-18       Impact factor: 16.971

10.  Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump AcrB.

Authors:  Thomas Eicher; Markus A Seeger; Claudio Anselmi; Wenchang Zhou; Lorenz Brandstätter; François Verrey; Kay Diederichs; José D Faraldo-Gómez; Klaas M Pos
Journal:  Elife       Date:  2014-09-19       Impact factor: 8.140

View more
  9 in total

1.  Amino Acid Substitution in the Major Multidrug Efflux Transporter Protein AcrB Contributes to Low Susceptibility to Azithromycin in Haemophilus influenzae.

Authors:  Shoji Seyama; Takeaki Wajima; Hidemasa Nakaminami; Norihisa Noguchi
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

2.  Conformational Dynamics of AcrA Govern Multidrug Efflux Pump Assembly.

Authors:  Anthony J Hazel; Narges Abdali; Inga V Leus; Jerry M Parks; Jeremy C Smith; Helen I Zgurskaya; James C Gumbart
Journal:  ACS Infect Dis       Date:  2019-09-26       Impact factor: 5.084

3.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

4.  Genome sequencing and assessment of plant growth-promoting properties of a Serratia marcescens strain isolated from vermicompost.

Authors:  Filipe P Matteoli; Hemanoel Passarelli-Araujo; Régis Josué A Reis; Letícia O da Rocha; Emanuel M de Souza; L Aravind; Fabio L Olivares; Thiago M Venancio
Journal:  BMC Genomics       Date:  2018-10-16       Impact factor: 3.969

5.  The effects of magainin 2-derived and rationally designed antimicrobial peptides on Mycoplasma pneumoniae.

Authors:  Katsuhiko Hayashi; Takashi Misawa; Chihiro Goto; Yosuke Demizu; Yukiko Hara-Kudo; Yutaka Kikuchi
Journal:  PLoS One       Date:  2022-01-24       Impact factor: 3.240

6.  Molecular Determinants for OMF Selectivity in Tripartite RND Multidrug Efflux Systems.

Authors:  Esther Boyer; Jean Dessolin; Margaux Lustig; Marion Decossas; Gilles Phan; Quentin Cece; Grégory Durand; Véronique Dubois; Joris Sansen; Jean-Christophe Taveau; Isabelle Broutin; Laetitia Daury; Olivier Lambert
Journal:  Antibiotics (Basel)       Date:  2022-01-18

7.  Acetylome and Succinylome Profiling of Edwardsiella tarda Reveals Key Roles of Both Lysine Acylations in Bacterial Antibiotic Resistance.

Authors:  Yuying Fu; Lishan Zhang; Huanhuan Song; Junyan Liao; Li Lin; Wenjia Jiang; Xiaoyun Wu; Guibin Wang
Journal:  Antibiotics (Basel)       Date:  2022-06-23

8.  Pan-genome diversification and recombination in Cronobacter sakazakii, an opportunistic pathogen in neonates, and insights to its xerotolerant lifestyle.

Authors:  Isaiah Paolo A Lee; Cheryl P Andam
Journal:  BMC Microbiol       Date:  2019-12-27       Impact factor: 3.605

Review 9.  Ever-Adapting RND Efflux Pumps in Gram-Negative Multidrug-Resistant Pathogens: A Race against Time.

Authors:  Martijn Zwama; Kunihiko Nishino
Journal:  Antibiotics (Basel)       Date:  2021-06-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.